The practice guideline 'vitiligo';Richtlijn 'vitiligo'

Nederlands Tijdschrift voor Geneeskunde

Volumn 150, Issue 36, 2006, Pages 1976-1981

  Menke, H E ^a   Van Everdingen, J J E ^b  

^a SINT FRANCISCUS GASTHUIS   (Netherlands)

^b Dutch Institute for Healthcare Improvement CBO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SUSPENSION; CLINICAL FEATURE; EPIDERMIS; EVIDENCE BASED MEDICINE; GENERAL PRACTITIONER; HUMAN; MEDICAL EXAMINATION; MEDICAL PRACTICE; MEDICAL SOCIETY; MEDICAL SPECIALIST; NETHERLANDS; PHOTOTHERAPY; PRACTICE GUIDELINE; REVIEW; SKIN TRANSPLANTATION; TREATMENT PLANNING; ULTRAVIOLET B RADIATION; VITILIGO;

DIAGNOSIS, DIFFERENTIAL; EVIDENCE-BASED MEDICINE; HUMANS; PHOTOTHERAPY; PRACTICE GUIDELINES; SKIN TRANSPLANTATION; VITILIGO;

EID: 33749265302     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Ongenae K, Geel N van, Naeyaert JM. Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res. 2003;16:90-100.
2. Njoo MD, Bossuyt PMM, Westerhof W. Management of vitiligo. Results of a questionnaire among dermatologists in the Netherlands. Int J Dermatol. 1999;38:866-72.
3. Ongenae K, Geel N van, Schepper S de, Haeghen Y van der, Naeyaert JM. Management of vitiligo patients and attitude of dermatologists towards vitiligo. Eur J Dermatol. 2004;14:177-81.
4. Papadopoulos L, Bor R, Legg C. Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy. Br J Med Psychol. 1999;72:385-96.
5. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol. 2000;42(2 Pt 1):245-53.
6. Parsad D, Pandhi R, Dogra S, Kanwar AJ, Kumar B. Dermatology life quality index score in vitiligo and its impact on the treatment outcome. Br J Dermatol. 2003;148:373-4.
7. Austin M. Fighting and living with vitiligo. J Am Acad Dermatol. 2004;51(1 Suppl):S7-8.
8. Grimes PE. White patches and bruised souls: advances in the pathogenesis and treatment of vitiligo. J Am Acad Dermatol. 2004;51 (1 Suppl):S5-7.
9. Ongenae K. Quality of life and management of vitiligo patients [proefschrift]. Gent: Universiteit Gent; 2004.
10. Njoo MD, Spuls PhI, Bos JD, Westerhof W, Bossuyt PMM. Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature. Arch Dermatol. 1998;134:1532-40.
11. Diffey BL. Factors affecting the choice of a ceiling on the number of exposures with TL01 ultraviolet B phototherapy. Br J Dermatol. 2003;149:428-30.
12. Köster W, Wiskemann A. Phototherapy with UV-B in vitiligo. Z Hautkr. 1990;65:1022-4.
13. Rie MA de, Pavel S. Fotodermatologie. Ned Tijdschr Geneeskd. 2002;146:1924-9.
14. Mosher DB, Parrish JA, Fitzpatrick TB. Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature. Br J Dermatol. 1977;97:669-79.
15. Thissen M, Westerhof W. Laser treatment for further depigmentation in vitiligo. Int J Dermatol. 1997;36:386-8.
16. Njoo MD, Vodegel RM, Westerhof W. Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser. J Am Acad Dermatol. 2000;42(5 Pt 1):760-9.
17. Geel N van. Evaluation of autologous non-cultured epidermal cell transplantation in vitiligo [proefschrift]. Gent: Universiteit Gent; 2005.